MAKEMYTRIP LIMITED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 103.75 USD | +0.93% |
|
+10.05% | +118.80% |
| Jul. 23 | Sector Update: Consumer Stocks Flat to Higher Pre-Bell Tuesday | MT |
| Jul. 23 | MakeMyTrip Q1 Adjusted Earnings, Revenue Rise | MT |
EPS & Dividend: MakeMyTrip Limited
| Fiscal Period: Marzo | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | 0.00315 | - |
| Rate of return | - | - | - | - | - | - | 0% | - |
| EPS 2 | -4.26 | -0.52 | -0.42 | -0.1 | 1.74 | 0.9683 | 1.596 | 2.115 |
| Distribution rate | - | - | - | - | - | - | 0.2% | - |
| Reference price 2 | 11.96 | 31.58 | 26.83 | 24.47 | 71.05 | 102.79 | 102.79 | 102.79 |
| Nbr of stocks (in thousands) | 102,990 | 103,255 | 104,733 | 105,274 | 109,065 | 109,782 | - | - |
| Announcement Date | 6/26/20 | 5/25/21 | 5/25/22 | 5/16/23 | 5/15/24 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: MakeMyTrip Limited
| 2024-10-28 | Q2 2025 Earnings Release (Projected) |
| 2025-01-22 | Q3 2025 Earnings Release (Projected) |
| 2025-05-13 | Q4 2025 Earnings Release (Projected) |
| 2025-07-28 | Q1 2026 Earnings Release (Projected) |
| Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | ||
|---|---|---|---|---|---|---|
| -.--% | +0.00% | 106.16x | 9.795 | 10.95x | ||
| +0.89% | +0.93% | 22.14x | -26.390600 | 5.91x | ||
| -.--% | -.--% | 15.71x | 1.612 | 3.76x | ||
| -.--% | -.--% | 15.94x | 22.03 | 1.42x | ||
| +0.71% | +0.77% | 15.28x | 1.487 | 1.31x | ||
| +3.31% | +3.69% | 15.56x | 3.327 | 1.25x | ||
| - | - | 77x | - | 10.34x | ||
| +0.67% | +1.33% | 24.46x | 2.724 | 4.77x | ||
| -.--% | -.--% | 28.65x | 4.831 | 3.49x | ||
| -.--% | -.--% | 118.49x | 2.077 | 0.87x | ||
| Average | +0.62% | +0.75% | 43.94x | 2.39 | 4.41x | |
| Weighted average by Cap. | +0.64% | +0.68% | 26.55x | -14.14 | 5.29x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Estimates Revisions:
More analyst reviews